Patents by Inventor Brian Ondek

Brian Ondek has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CD20 binding molecules
    Patent number: 8153125
    Abstract: The present invention relates to CD20 binding molecules and nucleic acid sequences encoding CD20 binding molecules. In particular, the present invention relates to CD20 binding molecules with a high binding affinity, and a low dissociation rate, with regard to human CD20. Preferably, the CD20 binding molecules of the present invention comprise light and/or heavy chain variable regions with fully human frameworks (e.g. human germline frameworks).
    Type: Grant
    Filed: May 20, 2004
    Date of Patent: April 10, 2012
    Assignee: Applied Molecular Evolution, Inc.
    Inventors: Jeffry D. Watkins, Julian Davies, David M. Marquis, Barrett W Allan, Brian Ondek
  • Cd20 binding molecules
    Publication number: 20060251652
    Abstract: The present invention relates to CD20 binding molecules and nucleic acid sequences encoding CD20 binding molecules. In particular, the present invention relates to CD20 binding molecules with a high binding affinity, and a low dissociation rate, with regard to human CD20. Preferably, the CD20 binding molecules of the present invention comprise light and/or heavy chain variable regions with fully human frameworks (e.g. human germline frameworks).
    Type: Application
    Filed: May 20, 2004
    Publication date: November 9, 2006
    Inventors: Jeffry Watkins, Julian Davies, David Marquis, Barrett Allan, Brian Ondek
  • CD20 binding molecules
    Publication number: 20050025764
    Abstract: The present invention relates to CD20 binding molecules and nucleic acid sequences encoding CD20 binding molecules. In particular, the present invention relates to CD20 binding molecules with a high binding affinity, and a low dissociation rate, with regard to human CD20. Preferably, the CD20 binding molecules of the present invention comprise light and/or heavy chain variable regions with fully human frameworks (e.g. human germline frameworks).
    Type: Application
    Filed: May 20, 2004
    Publication date: February 3, 2005
    Inventors: Jeffry Watkins, Julian Davies, David Marquis, Barrett Allan, Brian Ondek